| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Keith R. Abrams | Q51913713 |
| Gene Feder | Q60062039 | ||
| P2093 | author name string | R Chen | |
| M Sculpher | |||
| S Palmer | |||
| A Timmis | |||
| H Hemingway | |||
| M Shipley | |||
| M Henriksson | |||
| K McAllister | |||
| N Fitzpatrick | |||
| U Stenestrand | |||
| A Hingorani | |||
| B Keogh | |||
| J-C Kaski | |||
| M Janzon | |||
| J Damant | |||
| P433 | issue | 9 | |
| P921 | main subject | biomarker | Q864574 |
| systematic review | Q1504425 | ||
| revascularization | Q7317735 | ||
| P304 | page(s) | 1-151, iii-iv | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | Health Technology Assessment | Q15708880 |
| P1476 | title | The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model | |
| P478 | volume | 14 |
| Q57259767 | A method for the early health technology assessment of novel biomarker measurement in primary prevention programs |
| Q36787252 | Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology |
| Q33598869 | Assessing the cost effectiveness of using prognostic biomarkers with decision models: case study in prioritising patients waiting for coronary artery surgery |
| Q47377237 | Biomarkers: Delivering on the expectation of molecularly driven, quantitative health |
| Q38238285 | C-reactive protein and risk of fracture: a systematic review and dose-response meta-analysis of prospective cohort studies |
| Q55424395 | Cohort profile: the Coronary Artery disease Risk Determination In Innsbruck by diaGnostic ANgiography (CARDIIGAN) cohort. |
| Q38042441 | Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs |
| Q35485247 | Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses |
| Q28751824 | Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease |
| Q28744139 | Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis |
Search more.